•  
  •  
 

Abstract

Introduction.People with type 2 diabetes mellitus (T2DM) are at a higher risk of mortality from COVID-19. This study aimed to identify the relationship between T2DM and the outcome of COVID-19 patients in Sanglah Hospital Denpasar, Bali. Methods. An observational analytic study with a cross-sectional approach was conducted among COVID-19 patients. We used secondary data from the records of confirmed COVID-19 patients who were treated at Sanglah Hospital on 1 August 2020 – 28 February 2022. Sample were selected with total sampling technique. Results. There were 1,056 patients involved in this study. Most of the patients were male (n=571; 54.1%), with a median age of 59 years old. Most of the patients were categorized as severe COVID-19 (n=641; 60.7%). A total of 275 patients had T2DM (26.0%). Chi-square analysis showed a significant association of T2DM with mortality (PR=1.422; 95%CI=1.162-1.742; p=0.001), severe COVID-19 (PR=1.726; 95%CI=1.365-2.184; p<0.001), ventilator usage (PR=1.334; 95%CI=1.093-1.791; p=0.045), and longer hospitalization duration (PR=1.340; 95%CI=1.083-1.658; p=0.006) with T2DM. Logistic regression analysis showed significant association of T2DM with mortality (PR=1.536; 95%CI=1.110-2.125; p=0.010), severe COVID-19 (PR=1.704; 95%CI=1.233-2.356; p<0.001), and longer hospitalization duration (PR=1.615; 95%CI=1.191-2.190; p=0.002).

References

. Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-ncov) in Wuhan, China. J Med Virol. 2020;92(4):441–7.2. Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-COV-2 and COVID-19 in older adults: What we may expect regarding pathogenesis, immune responses, and outcomes. GeroScience. 2020;42(2):505–14.3. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020;323(13):1239.4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(10223):507–13.5. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-COV-2: A systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5.6. Guan W-jie, Ni Z-yi, Hu Y, Liang W-hua, Ou C-quan, He J-xing, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.7. Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 2020;8(4):e20.8. Wenham C, Smith J, Morgan R. COVID-19: The gendered impacts of the outbreak. Lancet. 2020;395(10227):846–8.9. Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol. 2017;56(3):308–21.10. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang Z-J. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020;323(13):1313.11. Guan W-jie, Ni Z-yi, Hu Y, Liang W-hua, Ou C-quan, He J-xing, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.12. Koh H, Moh A, Yeoh E, Lin Y, Low S, Ooi S, et al. Diabetes predicts severity of COVID-19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C-reactive protein. J Med Virol. 2021;93(5):3023-32.13. Atmaja KS, Wicaksana AAGOS, Putra IWAS, Putra WWS. Hubungan konsentrasi serum C-Reactive Protein dan D-dimer dengan derajat keparahan dan mortalitas pasien COVID-19. Intisari Sains Medis. 2021;12(2):680-5.14. Nata N, Rangsin R, Supasyndh O, Satirapoj B. Impaired glomerular filtration rate in type 2 diabetes mellitus subjects: a nationwide cross-sectional study in Thailand. J Diabetes Res. 2020;2020:6353949.15. Sugondo AT, Nuswantoro D, Notopuro PB, Ardiany D. Relationship between HbA1c levels with eGFR and blood pressure in type 2 diabetes mellitus patients at general hospital in Surabaya. Biomol Health Sci J. 2019;02(02):117-20.16. Pecly IMD, Azevedo RB, Muxfeldt ES, Botelho BG, Albuquerque GG, et al. COVID-19 and chronic kidney disease: a comprehensive review. J Bras Nefrol. 2021;43(3):383–99.17. Mehraeen E, Karimi A, Barzegary A, Vahedi F, Afsahi A, Dadras O, et al. Predictors of mortality in patients with COVID-19–a systematic review. Eur J Integr Med. 2020;40:101226. 18. Sousa G, Garces T, Cestari V, Florêncio R, Moreira T, Pereira M. Mortality and survival of COVID-19. Epidemiol Infect. 2020;148:e123.19. Mahlangu T, Dludla P, Nyambuya T, Mxinwa V, Mazibuko-Mbeje S, Cirilli I, et al. A systematic review on the functional role of Th1/Th2 cytokines in type 2 diabetes and related metabolic complications. Cytokine. 2020;126:154892. 20. Han M, Ma K, Wang X, Yan W, Wang H, You J, et al. Immunological Characteristics in type 2 diabetes mellitus among COVID-19 patients. Front Endocrinol (Lausanne). 2021;12:596518.21. Pouvreau C, Dayre A, Butkowski E, de Jong B, Jelinek H. Inflammation and oxidative stress markers in diabetes and hypertension. J Inflamm Res. 2018;11:61-8. 22. Wang X, Liu Z, Li J, Zhang J, Tian S, Lu S, et al. Impacts of type 2 diabetes on disease severity, therapeutic effect, and mortality of patients with COVID-19. J Clin Endocrinol Metab. 2020;105(12):dgaa535. 23. Soliman AT, Prabhakaran NA, Al Masalamani MS, De Sanctis V, Abu Khattab MA, Alsaud AE, et al. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: a comparative study. Acta Biomed.2020;91(3):e2020010. 24. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934.25. Vishnu CSK, Prateek SH, Samiran M, Kashvi G, Umair M, Anuj VS, et al. Transaminitis is an indicator of mortality in patients with COVID19: A retrospective cohort study. World J Hepatol. 2020;12(9):621-5.26. Meaghan MP, Luis HB, Elijah DL, Magdalena ES, Marcus RP, Elizabeth XZ, et al. Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large U.S. cohort. Hepatology. 2020;72(3): 811-5.27. Sarita RA, Ratha KV. Acute liver injury in COVID-19 infection: report from field hospital and COVID-19 situation update in association of Southeast Asian Nations (ASEAN). Eur J Mol Clin Med. 2020;7(10): 1216-8.28. Ruyi C, Jinshi Z, Yifan Z, Lin L, Yueming L, QIang H. Mortality in chronic kidney disease patients with COVID-19: A systematic review and meta-analysis. Int Urol Nephrol. 2021;53: 1625-6.29. Savas O, Kenan T, Mustafa A, Ali RO, Mehmet RA, Zeki A, Egemen C, et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transplant. 2020;35: 2084-7.30. Jia HN, Jamie SH, Rimda W, Mala S, Vipulbhai S, Susana H, Kenar DJ, Steven F. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98:1531-5.31. Carleigh H, Brooke L, Rajesh K, Venkata NSG. Diabetes, heart failure, and COVID-19: an update. Front Physiol. 2021;12:3-6.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.